title: The clinical trial model is up for review: time, expense, and quality of results are at issue, as is the relationship to drug pricing.
abstract: Costly medications have raised questions about the role that long, complex clinical trials play in drug pricing. Approval of a drug takes, on average, 14 years, costs more than $2 billion, and has a high risk of failure. Participants are seeking alternatives.
authors.forename: Stephen
authors.initials: S
authors.lastname: Barlas